Quince Therapeutics, Inc. (QNCX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2026-05-11. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

50.10M
Year ended 2025-12-31
+14.4%
3-year compound annual growth
2021-12-31: 29.72M2022-12-31: 33.50M2023-12-31: 37.24M2024-12-31: 43.26M2025-12-31: 50.10M50.10M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3150.10M+15.8%2026-04-10, From 2025-01-01
2024-12-3143.26M+16.2%2026-04-10, From 2024-01-01
2023-12-3137.24M+11.2%2025-03-24, From 2023-01-01
2022-12-3133.50M+12.7%2024-04-01, From 2022-01-01
2021-12-3129.72Mn/a2023-03-15, From 2021-01-01